Question 1

Which factors must you Consider when assessing a patient's risk for asthma
I.Family history
II.Race
III.Gender
IV.Age
V.Ethnicity
VI.Birth weight
VII.SocioeConomic status

Accepted Answer

A) I, II, III, IV, and V 
B) III, IV, V, and VI 
C) I, II, III, V, VI, and VII 
D) I, V, VI, and VII 
A) I, II, III, IV, and V 
B) III, IV, V, and VI 
C) I, II, III, V, VI, and VII 
D) I, V, VI, and VII

Question 2

Which of the following cells give rise to the chronic inflammation process
I.Basophils
II.Eosinophils
III.Lymphocytes (T cells and B cells)
IV.Monocytes
V.Neutrophils

Accepted Answer

A) I and III 
B) IV and V 
C) II and V 
D) III and IV 
A) I and III 
B) IV and V 
C) II and V 
D) III and IV

Question 3

Which of the following are Considered indoor allergenic triggers
I.Cockroaches
II.Dust mites
III.Wood and gas stoves
IV.TobacCo smoke
V.Mold

Accepted Answer

A) I, II, and V 
B) III, IV, and V 
C) II, III, and IV 
D) I, IV, and V 
A) I, II, and V 
B) III, IV, and V 
C) II, III, and IV 
D) I, IV, and V

Question 4

Predictors associated with increased risk of asthma exacerbations or death as a result of asthma include all of the following except: 
I.Two or more emergency department visits or hospitalizations within the past year
II.Patient cigarette use
III.Moderate airflow obstruction seen in pulmonary function testing
IV.Patient reporting being frightened by his or her asthma
V.Patient using medications as prescribed
VI.Numerous intubation and intensive care unit admissions in the past 5 years

Accepted Answer

A) I, III, IV, and V 
B) I, II, IV, and VI 
C) II, III, IV, and V 
D) II, IV, V, and VI 
A) I, III, IV, and V 
B) I, II, IV, and VI 
C) II, III, IV, and V 
D) II, IV, V, and VI

Question 5

What physiological and environmental mechanisms Contribute to nocturnal asthma symptoms
I.Sleep state-induced parasympathetic tone
II.Increased lung volume and subsequent airway smooth muscle uploading
III.Circadian rhythms
IV.Reduced nocturnal body temperature
V.Gastroesophageal reflux
VI.Obstructed sleep apnea

Accepted Answer

A) I, II, III, and IV 
B) II, III, IV, and V 
C) I, II, III, V, and VI 
D) I, III, IV, V, and VI 
A) I, II, III, and IV 
B) II, III, IV, and V 
C) I, II, III, V, and VI 
D) I, III, IV, V, and VI

Question 6

What Combination of drug therapy has significantly reduced symptoms and improved pulmonary function in patients admitted to the hospital for their asthma exacerbation
I.IV magnesium
II.Inhaled short-acting beta agonists
III.Systemic CortiCosteroids
IV.Inhaled magnesium sulfate

Accepted Answer

A) I, II, III, and IV 
B) II, III, and IV 
C) I, III, and IV 
D) I, II, and III 
A) I, II, III, and IV 
B) II, III, and IV 
C) I, III, and IV 
D) I, II, and III

Question 7

What are the most Common side effects seen with the use of short-acting beta agonists
I.Tremors
II.Tachycardia
III.Tachypnea
IV.Dizziness
V.Nervousness
VI.Blurred vision

Accepted Answer

A) I, II, III, IV, and V 
B) II, IV, V, and VI 
C) I, II, IV, and V 
D) I, II, III, IV, V, and VI 
A) I, II, III, IV, and V 
B) II, IV, V, and VI 
C) I, II, IV, and V 
D) I, II, III, IV, V, and VI

Question 8

Biomarkers of inflammation can be used to screen for diseases and can be obtained from which of the following
I.Urine
II.Blood
III.Sputum
IV.Feces
V.Exhaled CO₂

Accepted Answer

A) I, III, V, and VI 
B) II, IV, V, and VI 
C) I, II, III, and V 
D) I, III, and IV 
A) I, III, V, and VI 
B) II, IV, V, and VI 
C) I, II, III, and V 
D) I, III, and IV

Question 9

What test is instrumental in identifying clinical severity of airway hyperresponsiveness

Accepted Answer

A) Methacholine challenge 
B) Acetylcholine challenge 
C) Airway remodeling challenge 
D) Bronchodilator and peak flow testing 
A) Methacholine challenge 
B) Acetylcholine challenge 
C) Airway remodeling challenge 
D) Bronchodilator and peak flow testing

Which factors must you Consider when assessing a patient's risk for asthma I.Family history II.Race III.Gender IV.Age V.Ethnicity VI.Birth weight VII.SocioeConomic status

Which of the following cells give rise to the chronic inflammation process I.Basophils II.Eosinophils III.Lymphocytes (T cells and B cells) IV.Monocytes V.Neutrophils

Which of the following are Considered indoor allergenic triggers I.Cockroaches II.Dust mites III.Wood and gas stoves IV.TobacCo smoke V.Mold

What Combination of drug therapy has significantly reduced symptoms and improved pulmonary function in patients admitted to the hospital for their asthma exacerbation I.IV magnesium II.Inhaled short-acting beta agonists III.Systemic CortiCosteroids IV.Inhaled magnesium sulfate

What are the most Common side effects seen with the use of short-acting beta agonists I.Tremors II.Tachycardia III.Tachypnea IV.Dizziness V.Nervousness VI.Blurred vision

Biomarkers of inflammation can be used to screen for diseases and can be obtained from which of the following I.Urine II.Blood III.Sputum IV.Feces V.Exhaled CO₂

What test is instrumental in identifying clinical severity of airway hyperresponsiveness

Making Sense of Caring for Kids: a Different Approach to Respiratory Care

Fetal Cardiopulmonary Development

Resuscitation of the Newborn During Transition to Extrauterine Life

Respiratory Distress Syndrome

Apnea of Prematurity and Bronchopulmonary Dysplasia

Disease of Full-Term Infants

Common Neonatal Complications: Pulmonary Complications

Common Neonatal Complications: Multisystem Complications

Abdominal Defects

Airway Abnormalities

Acyanotic Heart Defects

Cyanotic Heart Defects

Pediatric Disease With Respiratory Implications

Pediatric Pulmonary Diseases

Pediatric Infectious Airway Diseases

Neuromuscular Disorders

Pediatric Diseases With Respiratory Implications

Neurological Accidents

Ethics in Perinatal and Pediatric Respiratory Care

Palliative and End of Life Care

Filters

Exam 13: Asthma

Which factors must you Consider when assessing a patient's risk for asthma I.Family history II.Race III.Gender IV.Age V.Ethnicity VI.Birth weight VII.SocioeConomic status

Which of the following cells give rise to the chronic inflammation process I.Basophils II.Eosinophils III.Lymphocytes (T cells and B cells) IV.Monocytes V.Neutrophils

Which of the following are Considered indoor allergenic triggers I.Cockroaches II.Dust mites III.Wood and gas stoves IV.TobacCo smoke V.Mold

What Combination of drug therapy has significantly reduced symptoms and improved pulmonary function in patients admitted to the hospital for their asthma exacerbation I.IV magnesium II.Inhaled short-acting beta agonists III.Systemic CortiCosteroids IV.Inhaled magnesium sulfate

What are the most Common side effects seen with the use of short-acting beta agonists I.Tremors II.Tachycardia III.Tachypnea IV.Dizziness V.Nervousness VI.Blurred vision

Biomarkers of inflammation can be used to screen for diseases and can be obtained from which of the following I.Urine II.Blood III.Sputum IV.Feces V.Exhaled CO₂

What test is instrumental in identifying clinical severity of airway hyperresponsiveness

Making Sense of Caring for Kids: a Different Approach to Respiratory Care

Fetal Cardiopulmonary Development

Resuscitation of the Newborn During Transition to Extrauterine Life

Respiratory Distress Syndrome

Apnea of Prematurity and Bronchopulmonary Dysplasia

Disease of Full-Term Infants

Common Neonatal Complications: Pulmonary Complications

Common Neonatal Complications: Multisystem Complications

Abdominal Defects

Airway Abnormalities

Acyanotic Heart Defects

Cyanotic Heart Defects

Pediatric Disease With Respiratory Implications

Pediatric Pulmonary Diseases

Pediatric Infectious Airway Diseases

Neuromuscular Disorders

Pediatric Diseases With Respiratory Implications

Neurological Accidents

Ethics in Perinatal and Pediatric Respiratory Care

Palliative and End of Life Care

Filters